AI, Supply Chain Restructuring, Obesity Treatments... Five Key Hot Issues in K-Bio
· Source: asiae.co.kr
In short
The Korean bio industry is undergoing significant transformation driven by supply chain restructuring, policy shifts, and technological advancements. Key issues include the impact of the U.S. Biosecure Act on global supply chains, the growth of obesity treatments and CDMO markets, and the integration of AI across the drug development value chain. The report highlights how AI has become essential infrastructure that will create competitive advantages in productivity and success rates for companies.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 4, 2026: Agentic AI Revolutionizes Supply Chains with Real-World Automation Gains
Tags: supply-chain, pharmaceutical, CDMO, forecasting, AI, biotech